Gene Therapy Biotech Founded to Save the CEO’s Daughter Goes Public in France – Labiotech.eu (blog)
|
Gene Therapy Biotech Founded to Save the CEO's Daughter Goes Public in France
Labiotech.eu (blog) Lysogene has raised €22.6M from its IPO on Euronext Paris that will contribute to the completion of clinical trials to treat the rare genetic diseases. Karen Aiach, CEO of Lysogene, started the company back in 2009 to develop a life-saving treatment … |
